Skip to main content

View full-text article in PMC

. Author manuscript; available in PMC: 2014 Jan 10.

Published in final edited form as: Oncol Nurs Forum. 2013 Jul;40(4):10.1188/13.ONF.383-393. doi: 10.1188/13.ONF.383-393

Table 2.

Summaries of Impedance and Arm Volume (N=46)

	Study Group
	MLD (N=16)	LLLT (N=15)	Combined MLT & LLLT (N=15)
	Median [IQR] (Min,Max)	Median [IQR] (Min,Max)	Median [IQR] (Min,Max)
Exratcellular Fluid (LDEX)^a(p = .984)
Baseline	27.7 [6,53] (−3,77)	39.3 [22,48] (3,104)	35.0 [15,56] (−14,93)
End of Study	17.8 [3,38] (−39,50)	28.0 [17,35] (0,47)	22.2 [11,37] (−3,44)
Effect Size	−0.54	−0.55	−0.53
Arm Volume^a(p = .422) (% Difference)
Baseline	11.7 [3,28] (−2,45)	23.2 [12,40] (3,66)	20.4 [10,35] (6,70)
End of Study	6.8 [0,17] (−4,33)	15.0 [3,23] (−2,39)	13.4 [2,24] (−4,43)
Effect size	−0.42	−0.64	−0.64

Note: The specific p-values report the results from the primary hypotheses of differences in the changes among the three study groups.

^a

Main effect of time of assessment, p < .001